Evidence map›Paper›PMID 42205672›Full record

ArticleCureus2026

L-2-Hydroxyglutaric Aciduria Due to the Homozygous Variant c.905C>T in L2HGDH Without Cognitive Deficits or Gait Disturbance: A Case Report.

Josef Finsterer, Awini Barwari

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Josef FinstererNeurology, Neurology and Neurophysiology Center, Vienna, AUT.
Awini BarwariNeurology, Neurology and Neurophysiology Center, Vienna, AUT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

L-2-hydroxyglutaric aciduria (L2HGA) is a rare, slowly progressive, autosomal recessive neurometabolic disorder caused by mutations in the L2HGDH gene and characterized by psychomotor developmental delay, cognitive impairment, epilepsy, dystonia, cerebellar ataxia, tremor, dysarthria, pyramidal signs, macrocephaly, leukoencephalopathy, and elevated L-2-hydroxyglutaric acid levels. To date, no case has been reported of a patient with L2HGA caused by the c.905C>T variant in L2HGDH presenting with epilepsy, tetraspasticity, tetraataxia, dysarthria, and dysmorphism, but without cognitive impairment or gait disturbance. The patient is a 22-year-old man from Syria with L2HGA, born to consanguineous parents, who presented with rare generalized seizures, mild tetraspasticity, tetraataxia, dysarthria, facial dysmorphism, and unilateral cryptorchism. His psychomotor development was normal. Cerebral MRI at the age of 18 revealed marked leukoencephalopathy, but no atrophy or involvement of the basal ganglia. Surprisingly, he showed no cognitive impairment, gait disturbances, or macrocephaly. He led an independent life as a mechanic and drove his own car. This case broadens the phenotypic spectrum of L2HGA and demonstrates that the c.905C>T variant in the L2HGDH gene can manifest phenotypically with only mild symptoms and without cognitive deficits or gait abnormalities. It also shows that some of these features may not be present in childhood but may develop only during adolescence or adulthood.

Indexed as

l-2-hydroxyglutaric acidurialeukoencephalopathymetabolic defectmyopathyseizures

Identifiers

PMID42205672
PMCPMC13211935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.